Aethlon Medical signals expanded Australian oncology enrollment strategy while operating loss narrows to $1.5M (NASDAQ:AEMD) - Reportify

Aethlon Medical signals expanded Australian oncology enrollment strategy while operating loss narrows to $1.5M (NASDAQ:AEMD)

Aethlon Medical(US:AEMD) Seeking Alpha·2025-11-13 07:32

技术访问问题 - 浏览器需启用Javascript和cookies以确保正常访问 [1] - 启用广告拦截器可能导致访问被阻止 [1] - 解决方法是禁用广告拦截器并刷新页面 [1]